Literature DB >> 6819847

Gold induced enterocolitis: case report and a review of the literature.

R Eaves, J Hansky, P Wallis.   

Abstract

The use of gold therapy in rheumatoid arthritis is not without risk. Although the better known side effects are bone marrow suppression and renal involvement, gold induced enterocolitis has been described. This paper reports a 59-year-old female recently treated with gold therapy for rheumatoid arthritis who developed bloody diarrhoea, toxic dilatation and perforation of her colon. The absence of features of inflammatory bowel disease or infection indicates gold as a possible causative agent. Pathogenesis, therapy and a review of the literature of gold induced enterocolitis are described.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6819847     DOI: 10.1111/j.1445-5994.1982.tb02649.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  5 in total

Review 1.  Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review.

Authors:  Taras Gout; Andrew J K Ostör; Muhammad K Nisar
Journal:  Clin Rheumatol       Date:  2011-08-11       Impact factor: 2.980

2.  Gold induced enterocolitis.

Authors:  C W Jackson; N Y Haboubi; P J Whorwell; P F Schofield
Journal:  Gut       Date:  1986-04       Impact factor: 23.059

3.  Gold induced enterocolitis complicated by cytomegalovirus infection: a previously unrecognised association.

Authors:  V Wong; J Wyatt; F Lewis; P Howdle
Journal:  Gut       Date:  1993-07       Impact factor: 23.059

Review 4.  Gold colitis induced by auranofin treatment of rheumatoid arthritis: case report and review of the literature.

Authors:  H E Langer; G Hartmann; G Heinemann; K Richter
Journal:  Ann Rheum Dis       Date:  1987-10       Impact factor: 19.103

5.  Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trial.

Authors:  Robert S Wallis; Sibuse Ginindza; Trevor Beattie; Nishanee Arjun; Morongwe Likoti; Vinodh A Edward; Mohammed Rassool; Khatija Ahmed; Katherine Fielding; Bintou A Ahidjo; Mboyo D T Vangu; Gavin Churchyard
Journal:  Lancet Respir Med       Date:  2021-03-16       Impact factor: 102.642

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.